| PDF (239kB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-335947
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.33594
Zusammenfassung
Background Selective cyclooxygenase-2 (COX-2) inhibitors are analgesic, antipyretic, and anti-inflammatory drugs. They have been found to inhibit the development of glioma in laboratory investigations. Whether these drugs reduce the risk of glioma incidence in humans is unknown. Methods We conducted a matched case-control analysis using the U.K.-based Clinical Practice Research Datalink (CPRD). ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags